+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

LAMEA Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

LAMEA Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028

  • Report
  • September 2022
  • 71 Pages
  • Middle East, Africa
From
Europe Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028

  • Report
  • September 2022
  • 71 Pages
  • Europe
From
North America Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028

  • Report
  • September 2022
  • 65 Pages
  • North America
From
Asia Pacific Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Insomnia Market Size, Share & Industry Trends Analysis Report by Distribution Channel, Therapy Type, Country and Growth Forecast, 2022-2028

  • Report
  • September 2022
  • 71 Pages
  • Asia Pacific
From
Thrombocytopenia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Thrombocytopenia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 602 Pages
  • Global
From
Company Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Company Snapshots: UK Pharmaceuticals

  • Newsletter
  • November 2024
  • 35 Pages
  • United Kingdom
From
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
Industry Snapshots: Japan Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: Japan Pharmaceuticals

  • Newsletter
  • November 2024
  • 75 Pages
  • Japan
From
Industry Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: UK Pharmaceuticals

  • Newsletter
  • November 2024
  • 50 Pages
  • United Kingdom
From
Company Snapshots: Japan Pharmaceutical - Product Thumbnail Image

Company Snapshots: Japan Pharmaceutical

  • Newsletter
  • November 2024
  • 35 Pages
  • Japan
From
Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 90 Pages
  • Global
From
Traumatic Brain Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Traumatic Brain Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 440 Pages
  • Global
From
Parkinson's Disease - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Parkinson's Disease - Global Drug Forecast and Market Analysis to 2029

  • Report
  • April 2021
  • 127 Pages
  • Global
From
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 74 Pages
  • Global
From
Neuroimmunology Drug Development - Thematic Research - Product Thumbnail Image

Neuroimmunology Drug Development - Thematic Research

  • Report
  • April 2022
  • 163 Pages
  • Global
From
Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027 - Product Thumbnail Image

Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027

  • Report
  • October 2018
  • 124 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Eisai Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Eisai Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2024
  • 71 Pages
From
Eisai Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Eisai Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2023
  • 35 Pages
From
Loading Indicator